Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 4 (2007), Issue 3 (March)

1. Therapy insight: peripheral arterial disease and diabetes--from pathogenesis to treatment guidelines.
   Nat Clin Pract Cardiovasc Med, 4(3): 151-62. [Abstract] [Full-text]
2. Therapy insight: diabetes and drug-eluting stents.
   Nat Clin Pract Cardiovasc Med, 4(3): 143-50. [Abstract] [Full-text]
3. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
   BMC Med Genet, 8: 5. [Abstract] [Full-text]
4. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis.
   Osteoporos Int, 18(4): 427-44. [Abstract] [Full-text]
5. Lack of effect of corticosteroid injection at the shoulder joint on blood glucose levels in diabetic patients.
   Clin Rheumatol, 26(4): 566-8. [Abstract] [Full-text]
6. A genome-wide search for linkage to renal function phenotypes in West Africans with type 2 diabetes.
   Am J Kidney Dis, 49(3): 394-400. [Abstract] [Full-text]
7. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study.
   Lancet, 369(9563): 750-6. [Abstract] [Full-text]
8. Viral infections as potential triggers of type 1 diabetes.
   Diabetes Metab Res Rev, 23(3): 169-83. [Abstract] [Full-text]
9. The spectrum of thyroid disorders in adult type 1 diabetes mellitus.
   Diabetes Metab Res Rev, 23(3): 227-33. [Abstract] [Full-text]
10. Effects of chronic hyperglycaemia on incident stroke in Hong Kong Chinese patients with type 2 diabetes.
    Diabetes Metab Res Rev, 23(3): 220-6. [Abstract] [Full-text]
11. Homocysteine and vitamin B(12) concentrations and mortality rates in type 2 diabetes.
    Diabetes Metab Res Rev, 23(3): 193-201. [Abstract] [Full-text]
12. Raised C-reactive protein levels in patients with recent onset type 1 diabetes.
    Diabetes Metab Res Rev, 23(3): 211-4. [Abstract] [Full-text]
13. Psychiatric and metabolic characteristics of childhood versus adult-onset obesity in patients seeking weight management.
    Eat Behav, 8(2): 266-76. [Abstract] [Full-text]
14. Specific associations of insulin resistance with impaired health-related quality of life in the Hertfordshire Cohort Study.
    Qual Life Res, 16(3): 429-36. [Abstract] [Full-text]
15. Effects of Type II diabetes on muscle microvascular oxygen pressures.
    Respir Physiol Neurobiol, 156(2): 187-95. [Abstract] [Full-text]
16. Manidipine plus delapril in patients with Type 2 diabetes and hypertension: reducing cardiovascular risk and end-organ damage.
    Expert Rev Cardiovasc Ther, 5(2): 147-59. [Abstract] [Full-text]
17. Advancing evidence-based care for diabetes: lessons from the Veterans Health Administration.
    Health Aff (Millwood), 26(2): w156-68. [Abstract] [Full-text]
18. Topical iodine facilitates transdermal delivery of insulin.
    J Control Release, 118(2): 185-8. [Abstract] [Full-text]
19. Evaluation of level of DNA damage in blood leukocytes of non-diabetic and diabetic rat exposed to cigarette smoke.
    Mutat Res, 628(2): 117-22. [Abstract] [Full-text]
20. "We are out of balance here": a Hmong cultural model of diabetes.
    J Immigr Minor Health, 9(3): 179-90. [Abstract] [Full-text]
21. Deficiency in angiotensin AT1a receptors prevents diabetes-induced hypertension.
    Am J Physiol Regul Integr Comp Physiol, 292(3): R1184-9. [Abstract] [Full-text]
22. Lack of central nitric oxide triggers erectile dysfunction in diabetes.
    Am J Physiol Regul Integr Comp Physiol, 292(3): R1158-64. [Abstract] [Full-text]
23. Growth factors in the treatment of diabetic foot ulcers: new technologies, any promises?
    Int J Low Extrem Wounds, 6(1): 37-53. [Abstract] [Full-text]
24. The diabetic foot: perspectives from Chennai, South India.
    Int J Low Extrem Wounds, 6(1): 34-6. [Abstract] [Full-text]
25. An evaluation of the value of group education in recently diagnosed diabetes mellitus.
    Int J Low Extrem Wounds, 6(1): 28-33. [Abstract] [Full-text]
26. Clinical outcomes of wide postsurgical lesions in the infected diabetic foot managed with 2 different local treatment regimes compared using a quasi-experimental study design: a preliminary communication.
    Int J Low Extrem Wounds, 6(1): 22-7. [Abstract] [Full-text]
27. The development and application of diabetic foot protocol in Chiang Mai University Hospital with an aim to reduce lower extremity amputation in Thai population: a preliminary communication.
    Int J Low Extrem Wounds, 6(1): 18-21. [Abstract] [Full-text]
28. Optimal organization of health care in diabetic foot disease: introduction to the Eurodiale study.
    Int J Low Extrem Wounds, 6(1): 11-7. [Abstract] [Full-text]
29. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis.
    Int J Cancer, 120(9): 1986-92. [Abstract] [Full-text]
30. Effect of oral magnesium sulfate administration on blood pressure and lipid profile in streptozocin diabetic rat.
    Eur J Pharmacol, 560(2): 201-5. [Abstract] [Full-text]
31. Involvement of mu1-opioid receptor on oxycodone-induced antinociception in diabetic mice.
    Eur J Pharmacol, 560(2): 160-2. [Abstract] [Full-text]
32. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity.
    Eur J Vasc Endovasc Surg, 33(4): 453-60. [Abstract] [Full-text]
33. Postural control following a self-initiated reaching task in type 2 diabetic patients and age-matched controls.
    Gait Posture, 25(4): 509-14. [Abstract] [Full-text]
34. Illness centrality and well-being among male and female early adolescents with diabetes.
    J Pediatr Psychol, 32(3): 260-72. [Abstract] [Full-text]
35. Brief report: initial testing of scales measuring parent and adolescent Perceptions of Adolescents' Assumption of Diabetes Management.
    J Pediatr Psychol, 32(3): 245-9. [Abstract] [Full-text]
36. Association of arterial wave properties and diastolic dysfunction in patients with type 2 diabetes mellitus.
    Am J Cardiol, 99(6): 844-8. [Abstract] [Full-text]
37. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus.
    Am J Cardiol, 99(6): 779-84. [Abstract] [Full-text]
38. Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: effects on the oxidative and antioxidative systems.
    Arch Med Res, 38(3): 276-83. [Abstract] [Full-text]
39. Mechanisms underlying the chronic pioglitazone treatment-induced improvement in the impaired endothelium-dependent relaxation seen in aortas from diabetic rats.
    Free Radic Biol Med, 42(7): 993-1007. [Abstract] [Full-text]
40. Antidiabetic effect of long-term supplementation with Siraitia grosvenori on the spontaneously diabetic Goto-Kakizaki rat.
    Br J Nutr, 97(4): 770-5. [Abstract] [Full-text]
41. Effect of dietary fish oil supplementation on cellular adhesion molecule expression and tissue myeloperoxidase activity in diabetic mice with sepsis.
    Br J Nutr, 97(4): 685-91. [Abstract] [Full-text]
42. On the supposed influence of milk homogenization on the risk of CVD, diabetes and allergy.
    Br J Nutr, 97(4): 598-610. [Abstract] [Full-text]
43. Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes.
    Clin Exp Immunol, 148(1): 17-31. [Abstract] [Full-text]
44. Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.
    Clin Exp Immunol, 148(1): 1-16. [Abstract] [Full-text]
45. Statin pre-treatment protects brain against focal cerebral ischemia in diabetic mice.
    J Surg Res, 138(2): 254-8. [Abstract] [Full-text]
46. Effects of a novel palatinose based enteral formula (MHN-01) carbohydrate-adjusted fluid diet in improving the metabolism of carbohydrates and lipids in patients with esophageal cancer complicated by diabetes mellitus.
    J Surg Res, 138(2): 231-40. [Abstract] [Full-text]
47. Method for chronological recording of antigen appearance in human head-hair shafts and its use for monitoring glycation products in diabetes.
    J Immunol Methods, 320(1): 1-17. [Abstract] [Full-text]
48. Aortic depressor nerve function examined in diabetic rats by means of two different approaches.
    J Neurosci Methods, 161(1): 17-22. [Abstract] [Full-text]
49. Electrochemical detection of HbA1c, a marker [correction of maker] for diabetes, using a flow immunoassay system.
    Biosens Bioelectron, 22(9): 2051-6. [Abstract] [Full-text]
50. Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial.
    Arch Ophthalmol, 125(3): 318-24. [Abstract] [Full-text]
51. Pulmonary function in patients with type 1 diabetes before and after simultaneous pancreas and kidney transplantation.
    Transplantation, 83(5): 566-9. [Abstract] [Full-text]
52. Does renal function deteriorate more rapidly in diabetic cardiac transplant recipients?
    Transplantation, 83(5): 550-3. [Abstract] [Full-text]
53. Pharmacist membership in a medical group's diabetes health management program.
    Am J Health Syst Pharm, 64(6): 617-21. [Abstract] [Full-text]
54. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy.
    Life Sci, 80(15): 1364-72. [Abstract] [Full-text]
55. Optimization of 1,4-diazepan-2-one containing dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes.
    Bioorg Med Chem Lett, 17(7): 1903-7. [Abstract] [Full-text]
56. PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children.
    Hum Genet, 121(2): 223-32. [Abstract] [Full-text]
57. Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes.
    Curr Med Res Opin, 23(3): 609-22. [Abstract] [Full-text]
58. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
    Curr Med Res Opin, 23(3): 489-94. [Abstract] [Full-text]
59. Factors affecting study efficiency and item non-response in health surveys in developing countries: the Jamaica national healthy lifestyle survey.
    BMC Med Res Methodol, 7: 13. [Abstract] [Full-text]
60. Macrosomic infants are not all equal.
    Aust N Z J Obstet Gynaecol, 47(2): 101-5. [Abstract] [Full-text]
61. Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection?
    Clin Microbiol Infect, 13(4): 351-3. [Abstract] [Full-text]
62. Decrease in the number of reported cases of zygomycosis among patients with diabetes mellitus: a hypothesis.
    Clin Infect Dis, 44(8): 1089-90. [Abstract] [Full-text]
63. Rehabilitation outcome following hip fracture surgery in elderly diabetics: a prospective cohort study of 224 patients.
    Disabil Rehabil, 29(4): 339-45. [Abstract] [Full-text]
64. Diabetes downregulates large-conductance Ca2+-activated potassium beta 1 channel subunit in retinal arteriolar smooth muscle.
    Circ Res, 100(5): 703-11. [Abstract] [Full-text]
65. Incidence of and risk factors for diabetes mellitus in cats that have undergone renal transplantation: 187 cases (1986-2005).
    J Am Vet Med Assoc, 230(6): 880-4. [Abstract] [Full-text]
66. Assessment of two culturally competent diabetes education methods: individual versus individual plus group education in Canadian Portuguese adults with type 2 diabetes.
    Ethn Health, 12(2): 163-87. [Abstract] [Full-text]
67. How do people with COPD or diabetes type 2 experience autonomy? An exploratory study.
    Disabil Rehabil, 29(6): 485-93. [Abstract] [Full-text]
68. Summary statement IV: Obesity and diabetes: opportunities for translation of basic research.
    Vascul Pharmacol, 46(5): 324-6. [Abstract] [Full-text]
69. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity.
    J Bone Miner Res, 22(4): 560-8. [Abstract] [Full-text]
70. Effect of Sclerocarya birrea (Anacardiaceae) stem bark methylene chloride/methanol extract on streptozotocin-diabetic rats.
    J Ethnopharmacol, 110(3): 434-8. [Abstract] [Full-text]
71. Effects of in vivo antioxidant enzyme activities of myrtle oil in normoglycaemic and alloxan diabetic rabbits.
    J Ethnopharmacol, 110(3): 498-503. [Abstract] [Full-text]
72. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study.
    J Am Acad Dermatol, 56(4): 629-34. [Abstract] [Full-text]
73. MICA marks additional risk factors for Type 1 diabetes on extended HLA haplotypes: an association and meta-analysis.
    Mol Immunol, 44(11): 2806-12. [Abstract] [Full-text]
74. CD8+ T lymphocytes specific for glutamic acid decarboxylase 90-98 epitope mediate diabetes in NOD SCID mouse.
    Mol Immunol, 44(11): 2950-60. [Abstract] [Full-text]
75. A novel multimeric form of FasL modulates the ability of diabetogenic T cells to mediate type 1 diabetes in an adoptive transfer model.
    Mol Immunol, 44(11): 2884-92. [Abstract] [Full-text]
76. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
    Exp Eye Res, 84(4): 745-52. [Abstract] [Full-text]
77. Characterization of immune complexes of idiotypic catalytic and anti-idiotypic inhibitory antibodies in plasma of type 1 diabetic subjects.
    Mol Immunol, 44(11): 2870-83. [Abstract] [Full-text]
78. The dual peroxisome proliferator-activated receptor alpha/gamma activator muraglitazar prevents the natural progression of diabetes in db/db mice.
    J Pharmacol Exp Ther, 321(1): 107-15. [Abstract] [Full-text]
79. Diabetic atherosclerosis mouse models.
    Atherosclerosis, 191(2): 241-9. [Abstract] [Full-text]
80. Glucose dynamics in Type I diabetes: insights from the classic and linear minimal models.
    Comput Biol Med, 37(5): 611-27. [Abstract] [Full-text]
81. Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT).
    Atherosclerosis, 191(2): 440-6. [Abstract] [Full-text]
82. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.
    Atherosclerosis, 191(2): 391-6. [Abstract] [Full-text]
83. Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for type 2 diabetes.
    Expert Opin Investig Drugs, 16(4): 533-45. [Abstract] [Full-text]
84. Exploring doctor-patient communication in immigrant Australians with type 2 diabetes: a qualitative study.
    J Gen Intern Med, 22(4): 459-63. [Abstract] [Full-text]
85. Physician compensation from salary and quality of diabetes care.
    J Gen Intern Med, 22(4): 448-52. [Abstract] [Full-text]
86. Factors influencing disease self-management among veterans with diabetes and poor glycemic control.
    J Gen Intern Med, 22(4): 442-7. [Abstract] [Full-text]
87. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Nephrology (Carlton), 12(2): 113-7. [Abstract] [Full-text]
88. Plasmid-based gene therapy of diabetes mellitus.
    Gene Ther, 14(7): 553-64. [Abstract] [Full-text]
89. The prevalence and severity of diabetic retinopathy, associated risk factors and vision loss in patients registered with type 2 diabetes in Luganville, Vanuatu.
    Br J Ophthalmol, 91(4): 415-9. [Abstract] [Full-text]
90. Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema.
    Br J Ophthalmol, 91(4): 449-54. [Abstract] [Full-text]
91. No association of SUMO4 M55V with autoimmune diabetes in Asian-Indian patients.
    Int J Immunogenet, 34(2): 137-42. [Abstract] [Full-text]
92. IL-18 gene promoter -137C/G and -607C/A polymorphisms in Chinese Han children with type 1 diabetes mellitus.
    Int J Immunogenet, 34(2): 75-9. [Abstract] [Full-text]
93. Dentists' management of the diabetic patient: contrasting generalists and specialists.
    Am J Public Health, 97(4): 725-30. [Abstract] [Full-text]
94. Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons.
    J Neurosci, 27(12): 3305-16. [Abstract] [Full-text]
95. Topiramate and physiologic measures of nerve function in polyneuropathy.
    Acta Neurol Scand, 115(4): 222-31. [Abstract] [Full-text]
96. Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage.
    J Neurol Sci, 255(1): 90-4. [Abstract] [Full-text]
97. Soluble tumor necrosis factor receptor 2 is independently associated with pulse wave velocity in nonobese Japanese patients with type 2 diabetes mellitus.
    Metabolism, 56(4): 571-7. [Abstract] [Full-text]
98. Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians.
    Metabolism, 56(4): 565-70. [Abstract] [Full-text]
99. Pioglitazone produces rapid and persistent reduction of vascular inflammation in patients with hypertension and type 2 diabetes mellitus who are receiving angiotensin II receptor blockers.
    Metabolism, 56(4): 559-64. [Abstract] [Full-text]
100. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
     Metabolism, 56(4): 552-8. [Abstract] [Full-text]
101. Marked decrease of apolipoprotein A-V in both diabetic and nondiabetic patients with end-stage renal disease.
     Metabolism, 56(4): 462-3. [Abstract] [Full-text]
102. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus.
     Metabolism, 56(4): 451-8. [Abstract] [Full-text]
103. Impaired wound healing after cerebral hypoxia-ischemia in the diabetic mouse.
     J Cereb Blood Flow Metab, 27(4): 710-8. [Abstract] [Full-text]
104. Diabetes mellitus promotes periodontal destruction in children.
     J Clin Periodontol, 34(4): 294-8. [Abstract] [Full-text]
105. Home telemonitoring of patients with diabetes: a systematic assessment of observed effects.
     J Eval Clin Pract, 13(2): 242-53. [Abstract] [Full-text]
106. Evaluation of the uses of aspirin, statins and ACEIs/ARBs in a diabetes outpatient population in southern Thailand.
     J Eval Clin Pract, 13(2): 221-6. [Abstract] [Full-text]
107. Structural and functional investigations of the murine cavernosal nerve: a model system for serial spatio-temporal study of autonomic neuropathy.
     BJU Int, 99(4): 916-24. [Abstract] [Full-text]
108. Use of insulin glargine during pregnancy: a case-control pilot study.
     BJOG, 114(4): 453-7. [Abstract] [Full-text]
109. Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital.
     Transl Res, 149(4): 196-204. [Abstract] [Full-text]
110. Use of intensified comprehensive cardiac rehabilitation to improve risk factor control in patients with type 2 diabetes mellitus or impaired glucose tolerance--the randomized DANish StUdy of impaired glucose metabolism in the settings of cardiac rehabilitation (DANSUK) study.
     Am Heart J, 153(4): 621-8. [Abstract] [Full-text]
111. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome.
     Am Heart J, 153(4): 552-8. [Abstract] [Full-text]
112. Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men.
     J Urol, 177(4): 1438-42. [Abstract] [Full-text]
113. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey.
     J Urol, 177(4): 1385-9. [Abstract] [Full-text]
114. Attenuated function and expression of P-glycoprotein at blood-brain barrier and increased brain distribution of phenobarbital in streptozotocin-induced diabetic mice.
     Eur J Pharmacol, 561(1): 226-32. [Abstract] [Full-text]
115. Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor.
     Life Sci, 80(18): 1721-8. [Abstract] [Full-text]
116. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats.
     Life Sci, 80(18): 1713-20. [Abstract] [Full-text]
117. Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats.
     Eur J Pharmacol, 561(1): 144-50. [Abstract] [Full-text]
118. Mechanisms of inhibited liver tissue repair in toxicant challenged type 2 diabetic rats.
     Toxicology, 232(3): 200-15. [Abstract] [Full-text]
119. Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS.
     Eur J Pharmacol, 561(1): 121-8. [Abstract] [Full-text]
120. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
     Eur J Pharmacol, 561(1): 63-71. [Abstract] [Full-text]
121. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis.
     Nephrol Dial Transplant, 22(4): 1184-9. [Abstract] [Full-text]
122. Racial disparities in diabetes a century ago: evidence from the pension files of US Civil War veterans.
     Soc Sci Med, 64(8): 1766-75. [Abstract] [Full-text]
123. A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans.
     Nephrol Dial Transplant, 22(4): 1131-5. [Abstract] [Full-text]
124. Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes.
     J Biol Chem, 282(13): 9364-71. [Abstract] [Full-text]
125. Introduction and evaluation of a computerised insulin protocol.
     Intensive Care Med, 33(4): 591-6. [Abstract] [Full-text]
126. Urinary tract infections in cats with hyperthyroidism, diabetes mellitus and chronic kidney disease.
     J Feline Med Surg, 9(2): 124-32. [Abstract] [Full-text]
127. Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries.
     J Nucl Cardiol, 14(2): 194-9. [Abstract] [Full-text]
128. Nodular glomerulosclerosis: renal lesions in chronic smokers mimic chronic thrombotic microangiopathy and hypertensive lesions.
     Am J Kidney Dis, 49(4): 552-9. [Abstract] [Full-text]
129. Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity.
     Am J Hypertens, 20(4): 431-6. [Abstract] [Full-text]
130. Valsartan but not atenolol improves vascular pathology in diabetic Ren-2 rat retina.
     Am J Hypertens, 20(4): 423-30. [Abstract] [Full-text]
131. Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria.
     Am J Hypertens, 20(4): 417-22. [Abstract] [Full-text]
132. Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus.
     Biochem Pharmacol, 73(9): 1367-75. [Abstract] [Full-text]
133. Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss.
     Kidney Int, 71(7): 637-45. [Abstract] [Full-text]
134. Type 2 diabetes and tuberculosis in a dynamic bi-national border population.
     Epidemiol Infect, 135(3): 483-91. [Abstract] [Full-text]
135. Can ultrasound fetal biometry predict fetal hyperinsulinaemia at delivery in pregnancy complicated by maternal diabetes?
     Eur J Obstet Gynecol Reprod Biol, 131(2): 146-50. [Abstract] [Full-text]
136. Retinal arteriolar diameter, blood velocity, and blood flow response to an isocapnic hyperoxic provocation in early sight-threatening diabetic retinopathy.
     Invest Ophthalmol Vis Sci, 48(4): 1744-50. [Abstract] [Full-text]
137. Sequence variation within the major histocompatibility complex subregion centromeric of HLA class II in type 1 diabetes.
     Tissue Antigens, 69(4): 348-53. [Abstract] [Full-text]
138. African Americans and diabetes: spiritual role of the health care provider in self-management.
     Res Nurs Health, 30(2): 164-74. [Abstract] [Full-text]
139. Coping and psychosocial adaptation to Type 2 diabetes in older Blacks born in the Southern US and the Caribbean.
     Res Nurs Health, 30(2): 151-63. [Abstract] [Full-text]
140. Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations.
     J Am Soc Nephrol, 18(4): 1284-91. [Abstract] [Full-text]
141. Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice.
     J Am Soc Nephrol, 18(4): 1227-38. [Abstract] [Full-text]
142. Immunoisolating pancreatic islets by encapsulation with selective withdrawal.
     Small, 3(4): 683-90. [Abstract] [Full-text]
143. Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study.
     Stroke, 38(4): 1154-60. [Abstract] [Full-text]
144. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.
     J Am Soc Nephrol, 18(4): 1353-61. [Abstract] [Full-text]
145. Altered promoter recycling rates contribute to dominant-negative activity of human peroxisome proliferator-activated receptor-gamma mutations associated with diabetes.
     Mol Endocrinol, 21(4): 857-64. [Abstract] [Full-text]
146. Inhibition of UCP2 expression reverses diet-induced diabetes mellitus by effects on both insulin secretion and action.
     FASEB J, 21(4): 1153-63. [Abstract] [Full-text]
147. Fasting glucose in acute myocardial infarction: incremental value for long-term mortality and relationship with left ventricular systolic function.
     Diabetes Care, 30(4): 960-6. [Abstract] [Full-text]
148. Sex-specific determinants of left ventricular mass in pre-diabetic and type 2 diabetic subjects: the Augsburg Diabetes Family Study.
     Diabetes Care, 30(4): 946-52. [Abstract] [Full-text]
149. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
     Diabetes Care, 30(4): 932-8. [Abstract] [Full-text]
150. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.
     Diabetes Care, 30(4): 911-7. [Abstract] [Full-text]
151. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
     Diabetes Care, 30(4): 896-902. [Abstract] [Full-text]
152. Spatiotemporal trends and age-period-cohort modeling of the incidence of type 1 diabetes among children aged <15 years in Norway 1973-1982 and 1989-2003.
     Diabetes Care, 30(4): 884-9. [Abstract] [Full-text]
153. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis.
     Diabetes Care, 30(4): 878-83. [Abstract] [Full-text]
154. Ketoacidosis at diagnosis of type 1 diabetes in children in northern Finland: temporal changes over 20 years.
     Diabetes Care, 30(4): 861-6. [Abstract] [Full-text]
155. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
     Diabetes Care, 30(4): 854-60. [Abstract] [Full-text]
156. Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004.
     Diabetes Care, 30(4): 848-53. [Abstract] [Full-text]
157. The risk of hip fractures in older individuals with diabetes: a population-based study.
     Diabetes Care, 30(4): 835-41. [Abstract] [Full-text]
158. Serum selenium and diabetes in U.S. adults.
     Diabetes Care, 30(4): 829-34. [Abstract] [Full-text]
159. The effect of cinnamon on A1C among adolescents with type 1 diabetes.
     Diabetes Care, 30(4): 813-6. [Abstract] [Full-text]
160. Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes.
     Diabetes Care, 30(4): 801-6. [Abstract] [Full-text]
161. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study.
     Diabetes Care, 30(4): 790-4. [Abstract] [Full-text]
162. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women.
     Diabetes Care, 30(4): 771-6. [Abstract] [Full-text]
163. The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice.
     Am J Pathol, 170(4): 1267-76. [Abstract] [Full-text]
164. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing.
     Am J Pathol, 170(4): 1178-91. [Abstract] [Full-text]
165. Diabetic retinopathy and coronary implantation of sirolimus-eluting stents.
     J Interv Cardiol, 20(2): 122-31. [Abstract] [Full-text]
166. Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes.
     Diabetes Obes Metab, 9(3): 438-40. [Abstract] [Full-text]
167. PREDICTIVE- a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort.
     Diabetes Obes Metab, 9(3): 428-34. [Abstract] [Full-text]
168. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study.
     Diabetes Obes Metab, 9(3): 418-27. [Abstract] [Full-text]
169. beta-blocker use and diabetes symptom score: results from the GEMINI study.
     Diabetes Obes Metab, 9(3): 408-17. [Abstract] [Full-text]
170. Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial.
     Diabetes Obes Metab, 9(3): 394-407. [Abstract] [Full-text]
171. Weight gain in type 2 diabetes mellitus.
     Diabetes Obes Metab, 9(3): 386-93. [Abstract] [Full-text]
172. Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes.
     Diabetes Obes Metab, 9(3): 360-8. [Abstract] [Full-text]
173. IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients.
     Diabetes Obes Metab, 9(3): 350-3. [Abstract] [Full-text]
174. A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38).
     Diabetes Obes Metab, 9(3): 337-43. [Abstract] [Full-text]
175. Short-term effects of metformin in type 2 diabetes.
     Diabetes Obes Metab, 9(3): 330-6. [Abstract] [Full-text]
176. Diagnostic utility of brain-natriuretic peptide for left ventricular diastolic dysfunction in asymptomatic type 2 diabetic patients.
     Diabetes Obes Metab, 9(3): 323-9. [Abstract] [Full-text]
177. Influences of diabetes (db/db), obese (ob/ob) and dystrophic (dy/dy) genotype mutations on hind limb bone maturation: a morphometric, radiological and cytochemical indices analysis.
     Diabetes Obes Metab, 9(3): 311-22. [Abstract] [Full-text]
178. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
     Diabetes Obes Metab, 9(3): 290-9. [Abstract] [Full-text]
179. Diabetes as a risk factor for cardiac conduction defects: a review.
     Diabetes Obes Metab, 9(3): 276-81. [Abstract] [Full-text]
180. Advanced glycation endproducts: what is their relevance to diabetic complications?
     Diabetes Obes Metab, 9(3): 233-45. [Abstract] [Full-text]
181. Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.
     Diabetes Obes Metab, 9(3): 218-32. [Abstract] [Full-text]
182. Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus.
     J Intern Med, 261(4): 392-8. [Abstract] [Full-text]
183. Renal functional changes in relation to hemodynamic parameters during exercise test in normoalbuminuric insulin-dependent children.
     Acta Paediatr, 96(4): 548-51. [Abstract] [Full-text]
184. The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes.
     Diabetes Care, 30(4): 903-10. [Abstract] [Full-text]
185. Prenatal exposures and glucose metabolism in adulthood: are effects mediated through birth weight and adiposity?
     Diabetes Care, 30(4): 918-24. [Abstract] [Full-text]
186. Influence of breastfeeding on obesity and type 2 diabetes risk factors in Latino youth with a family history of type 2 diabetes.
     Diabetes Care, 30(4): 784-9. [Abstract] [Full-text]
187. Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.
     Diabetes Care, 30(4): 890-5. [Abstract] [Full-text]
188. Inference on haplotype/disease association using parent-affected-child data: the projection conditional on parental haplotypes method.
     Genet Epidemiol, 31(3): 211-23. [Abstract] [Full-text]
189. Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetes.
     Diabetes Care, 30(4): 795-800. [Abstract] [Full-text]
190. Effects of treatment targets on subsequent cardiovascular events in Chinese patients with type 2 diabetes.
     Diabetes Care, 30(4): 953-9. [Abstract] [Full-text]
191. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management.
     Diabetes Care, 30(4): 807-12. [Abstract] [Full-text]
192. Does patient behavior or access factors have the largest influence on screening in type 1 diabetes?
     Diabetes Care, 30(4): 867-71. [Abstract] [Full-text]
193. Overexpression of GLUT5 in diabetic muscle is reversed by pioglitazone.
     Diabetes Care, 30(4): 925-31. [Abstract] [Full-text]
194. Type 2 diabetes and the risk of Parkinson's disease.
     Diabetes Care, 30(4): 842-7. [Abstract] [Full-text]
195. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy.
     Diabetes Care, 30(4): 823-8. [Abstract] [Full-text]
196. Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques?
     Circ Res, 100(6): 769-81. [Abstract] [Full-text]
197. Sociodemographic characteristics and diabetes predict invalid self-reported non-smoking in a population-based study of U.S. adults.
     BMC Public Health, 7: 33. [Abstract] [Full-text]
198. Toward further mapping of the association between the IL2RA locus and type 1 diabetes.
     Diabetes, 56(4): 1174-6. [Abstract] [Full-text]
199. Genome-wide linkage analyses to identify Loci for diabetic retinopathy.
     Diabetes, 56(4): 1160-6. [Abstract] [Full-text]
200. Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program.
     Diabetes, 56(4): 1153-9. [Abstract] [Full-text]
201. Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes.
     Diabetes, 56(4): 1113-9. [Abstract] [Full-text]
202. Minimal impact of a de novo-expressed beta-cell autoantigen on spontaneous diabetes development in NOD mice.
     Diabetes, 56(4): 1059-68. [Abstract] [Full-text]
203. Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor.
     Diabetes, 56(4): 984-91. [Abstract] [Full-text]
204. Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study.
     Diabetes, 56(4): 975-83. [Abstract] [Full-text]
205. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells.
     Diabetes, 56(4): 960-7. [Abstract] [Full-text]
206. Ubiquitinated-protein aggregates form in pancreatic beta-cells during diabetes-induced oxidative stress and are regulated by autophagy.
     Diabetes, 56(4): 930-9. [Abstract] [Full-text]
207. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
     J Neurochem, 101(1): 41-56. [Abstract] [Full-text]
208. Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
     Diabetes, 56(4): 1181-6. [Abstract] [Full-text]
209. Characterization of donor dendritic cells and enhancement of dendritic cell efflux with CC-chemokine ligand 21: a novel strategy to prolong islet allograft survival.
     Diabetes, 56(4): 912-20. [Abstract] [Full-text]
210. A prospective study of childhood and adult socioeconomic status and incidence of type 2 diabetes in women.
     Am J Epidemiol, 165(8): 882-9. [Abstract] [Full-text]
211. Renal effects of S18886 (Terutroban), a TP receptor antagonist, in an experimental model of type 2 diabetes.
     Diabetes, 56(4): 968-74. [Abstract] [Full-text]
212. A genome-wide linkage scan for diabetic retinopathy susceptibility genes in Mexican Americans with type 2 diabetes from Starr County, Texas.
     Diabetes, 56(4): 1167-73. [Abstract] [Full-text]
213. SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes.
     Diabetes, 56(4): 1177-80. [Abstract] [Full-text]
214. Evidence for D2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats.
     J Neurochem, 101(1): 151-9. [Abstract] [Full-text]
215. Birth weight and subsequent risk of type 2 diabetes: a meta-analysis.
     Am J Epidemiol, 165(8): 849-57. [Abstract] [Full-text]

© 2004-2010 Diabetes Research Today. All Rights Reserved.